2021
Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
Mukhatayeva A, Mustafa A, Dzissyuk N, Issanov A, Bayserkin B, Vermund SH, Ali S. Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan. Scientific Reports 2021, 11: 13542. PMID: 34188081, PMCID: PMC8241865, DOI: 10.1038/s41598-021-92688-w.Peer-Reviewed Original ResearchMeSH KeywordsAdultCoinfectionFemaleHepatitis BHepatitis C, ChronicHIV InfectionsHumansKazakhstanMaleTuberculosisConceptsStudy participantsHepatitis CHepatitis BRegular screeningHIV-positive study participantsHCV/HBVHIV-positive patientsTB/HIVHIV/HCVDirect acting antiviralsHIV/tuberculosisOpiate substitution therapyInjection drug useHarm reduction effortsAvailability of ARTHCV infectionTB infectionActing antiviralsCertain age groupsPositive patientsHIV infectionHIV prevalenceSubstitution therapyVaccination protocolsQuadruple infections
2020
Confronting Structural Racism in the Prevention and Control of Tuberculosis in the United States
Asabor EN, Vermund SH. Confronting Structural Racism in the Prevention and Control of Tuberculosis in the United States. Clinical Infectious Diseases 2020, 73: e3531-e3535. PMID: 33242078, PMCID: PMC8563219, DOI: 10.1093/cid/ciaa1763.Commentaries, Editorials and LettersConceptsStructural racismPeople of colorLow-income workersUnited StatesRacist policiesDisproportionate incarcerationState governmentsVulnerable communitiesMarginalized populationsCrowded prisonsRecent immigrantsHealth servicesEssential health servicesRacismImmigrantsIncarcerationPoor accessAffordable careKey populationsNational averagePreventive health servicesControl of tuberculosisPeopleGovernmentBIPOC
2013
Can Combination Prevention Strategies Reduce HIV Transmission in Generalized Epidemic Settings in Africa? The HPTN 071 (PopART) Study Plan in South Africa and Zambia
Vermund SH, Fidler SJ, Ayles H, Beyers N, Hayes RJ. Can Combination Prevention Strategies Reduce HIV Transmission in Generalized Epidemic Settings in Africa? The HPTN 071 (PopART) Study Plan in South Africa and Zambia. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2013, 63: s221-s227. PMID: 23764639, PMCID: PMC3739051, DOI: 10.1097/qai.0b013e318299c3f4.Peer-Reviewed Original ResearchConceptsHIV Prevention Trials NetworkHPTN 071 (PopART) studyHPTN 071HIV incidenceHIV transmissionHome-based HIV testingVoluntary medical male circumcisionGeneralized epidemic settingsLinkage of HIVUniversal antiretroviral therapyChild HIV transmissionPrevention of motherHIV viral loadCommunity health workersMedical male circumcisionCommunity-randomized trialIntervention strategiesCombination prevention strategiesAntiretroviral therapyHIV acquisitionSeropositive personsTuberculosis servicesHIV testingViral loadTuberculosis transmission
2010
Effect of treating co-infections on HIV-1 viral load: a systematic review
Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. The Lancet Infectious Diseases 2010, 10: 455-463. PMID: 20610327, PMCID: PMC3071714, DOI: 10.1016/s1473-3099(10)70093-1.Peer-Reviewed Original ResearchConceptsViral load differencesViral loadPlasma HIV-1 RNA concentrationSystematic reviewMean plasma viral loadPlasma HIV RNA concentrationHIV-1 RNA concentrationsHIV-1 viral loadHIV RNA concentrationPlasma viral loadHIV transmission riskViral load reductionNon-pathogenic infectionsCo-infecting pathogensSyphilis treatmentHIV progressionTuberculosis treatmentEligible studiesPopulation-level benefitsTransmission riskLow-income countriesHIVTreatmentInfectionReview
2004
Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy
Reid SE, Reid CA, Vermund SH. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. International Journal Of STD & AIDS 2004, 15: 713-716. PMID: 15537453, DOI: 10.1258/0956462042395195.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyInfected personsAntiretroviral treatment programAntiretroviral drug therapyHuman immunodeficiency virusResource-limited settingsAdherence strategiesImmunodeficiency virusSaharan AfricaAdequate adherenceDrug therapyDrug costsLeprosy controlTreatment programTherapyTuberculosisLeprosyAdherenceControl programs
1989
A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
Selwyn P, Hartel D, Lewis V, Schoenbaum E, Vermund S, Klein R, Walker A, Friedland G. A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection. New England Journal Of Medicine 1989, 320: 545-550. PMID: 2915665, DOI: 10.1056/nejm198903023200901.Peer-Reviewed Original ResearchConceptsHIV-seropositive subjectsIntravenous drug usersPositive PPD testHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionActive tuberculosisPPD testDrug usersSeronegative subjectsSeropositive subjectsTuberculous infectionSkin testingVirus infectionHIV-seronegative intravenous drug usersHIV-seronegative subjectsLatent tuberculous infectionRisk of tuberculosisTuberculin skin testingCases of tuberculosisMethadone maintenance programHIV antibodiesHIV-seropositiveHIV infectionProspective studyProtein derivative (PPD) tuberculin